Duloxetine HCL DR 60 MG cap 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26F8AQK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,063
Award facts
- Contract value 100% obligated
- $3,062.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $3,062.56 delivery order to Amerisourcebergen Drug Corp on May 7, 2026, for 1,000 capsules of Duloxetine HCL DR 60 mg, with ultimate completion on May 8, 2026.
Place of performance is Conshohocken, PA. The order carries firm fixed-price pricing and no set-aside. Amerisourcebergen operates as the execution entity for DLA pharmaceutical distribution under its parent company Cencora, Inc.
Quick answers
Who was awarded contract SPE2DR26F8AQK?
SPE2DR26F8AQK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 7, 2026.
How much is contract SPE2DR26F8AQK worth?
The government has obligated $3,063 on SPE2DR26F8AQK.
Is contract SPE2DR26F8AQK an order under another contract?
Yes. SPE2DR26F8AQK is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F8AQK competed?
The extent of competition for SPE2DR26F8AQK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award